{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:54:55Z","timestamp":1788540895133,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013294","name":"Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Umwelt und Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jcin.2024.03.015","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T14:54:23Z","timestamp":1715612063000},"page":"1134-1144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions"],"prefix":"10.1016","volume":"17","author":[{"given":"Tim","family":"Wittig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Fu\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Thieme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Maiwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"D\u00fcsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Konert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dierk","family":"Scheinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5680-1072","authenticated-orcid":false,"given":"Sabine","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jcin.2024.03.015_bib1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global Burden of Cardiovascular Diseases and Risks Collaborators. Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","author":"Mensah","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2024.03.015_bib2","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jacc.2016.02.040","article-title":"Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003-2011","volume":"67","author":"Agarwal","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2024.03.015_bib3","first-page":"910","article-title":"Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease","volume":"69","author":"Rocha-Singh","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.03.015_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.jcin.2024.03.015_bib5","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2024.03.015_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Interv"},{"issue":"5","key":"10.1016\/j.jcin.2024.03.015_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jcin.2024.03.015_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/1526602817708778","article-title":"A\u00a0quantitative angiographic comparison of restenotic tissue following placement of drug-eluting stents and bare metal stents in symptomatic patients with femoropopliteal disease","volume":"24","author":"Ansel","year":"2017","journal-title":"J\u00a0Endovasc Ther"},{"issue":"23","key":"10.1016\/j.jcin.2024.03.015_bib9","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcin.2018.08.034","article-title":"Sustainable antirestenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European randomized clinical trial 2-year results","volume":"11","author":"Brodmann","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"10","key":"10.1016\/j.jcin.2024.03.015_bib10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jcin.2018.01.276","article-title":"12-Month results from the first-in-human randomized study of the Ranger paclitaxel-coated balloon for femoropopliteal treatment","volume":"11","author":"Steiner","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"6","key":"10.1016\/j.jcin.2024.03.015_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions","volume":"12","author":"Laird","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.jcin.2024.03.015_bib12","article-title":"Atherectomy for peripheral arterial disease","volume":"9","author":"Wardle","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jcin.2024.03.015_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/15266028221120752","article-title":"Vessel preparation in infrapopliteal arterial disease: a systematic review and meta-analysis","volume":"31","author":"Nugteren","year":"2024","journal-title":"J\u00a0Endovasc Ther"},{"issue":"4","key":"10.1016\/j.jcin.2024.03.015_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ahj.2014.11.016","article-title":"Drug-coated balloons to improve femoropopliteal artery patency: rationale and design of the LEVANT 2 trial","volume":"169","author":"Jaff","year":"2015","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.jcin.2024.03.015_bib15","first-page":"549","article-title":"Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: the VIVA REALITY study","volume":"98","author":"Rocha-Singh","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.03.015_bib16","first-page":"E212","article-title":"Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications","volume":"83","author":"Rocha-Singh","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.03.015_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","article-title":"Two-year efficacy and safety results from the IMPERIAL randomized study of the Eluvia polymer-coated drug-eluting stent and the Zilver PTX polymer-free drug-coated stent","volume":"44","author":"M\u00fcller-H\u00fclsbeck","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jcin.2024.03.015_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcin.2021.01.026","article-title":"2-Year outcomes of the Eluvia drug-eluting stent for the treatment of complex femoropopliteal lesions","volume":"14","author":"Stavroulakis","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2024.03.015_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcin.2022.01.019","article-title":"1-Year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: predictors of restenosis and aneurysmal degeneration","volume":"15","author":"Iida","year":"2022","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"21","key":"10.1016\/j.jcin.2024.03.015_bib20","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.122.059606","article-title":"Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: primary results of the EMINENT randomized trial","volume":"146","author":"Gou\u00ebffic","year":"2022","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jcin.2024.03.015_bib21","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jcin.2017.04.041","article-title":"The 24-month results of the Lutonix Global SFA Registry: worldwide experience with Lutonix drug-coated balloon","volume":"10","author":"Thieme","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"11","key":"10.1016\/j.jcin.2024.03.015_bib22","doi-asserted-by":"crossref","first-page":"e940","DOI":"10.4244\/EIJ-D-21-01098","article-title":"Paclitaxel-coated balloons for femoropopliteal peripheral arterial disease: final five-year results of the IN.PACT global study","volume":"18","author":"Zeller","year":"2022","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.jcin.2024.03.015_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1526602820901723","article-title":"Effectiveness and safety of a paclitaxel-eluting stent for superficial femoral artery lesions up to 190\u00a0mm: one-year outcomes of the single-arm IMPERIAL long lesion substudy of the Eluvia drug-eluting stent","volume":"27","author":"Golzar","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2024.03.015_bib24","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jvir.2011.05.013","article-title":"Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial","volume":"22","author":"Shammas","year":"2011","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"2","key":"10.1016\/j.jcin.2024.03.015_bib25","first-page":"236","article-title":"Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca\u207a\u207a trial","volume":"84","author":"Roberts","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"issue":"13","key":"10.1016\/j.jcin.2024.03.015_bib26","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2022.06.043","article-title":"Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention","volume":"80","author":"Krishnan","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jcin.2024.03.015_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2019.04.057","article-title":"Drug-eluting balloon versus drug-eluting stent for complex femoropopliteal arterial lesions: the DRASTICO study","volume":"74","author":"Liistro","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jcin.2024.03.015_bib28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.jcin.2024.03.015_bib29","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.jcin.2023.04.037","article-title":"Hypoechoic halo imaging findings following femoropopliteal artery stent implantation: risk factors and clinical outcomes","volume":"16","author":"Holden","year":"2023","journal-title":"J\u00a0Am Coll Cardiol Intv"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879824005776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879824005776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:18:18Z","timestamp":1770250698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879824005776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1936879824005776"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2024.03.015","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2024.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}